Data Bridge Market Research recently conducted an extensive market intelligence study, diving deep into the House Dust Mite Allergy Market. The resulting report stands out with its visually engaging layout, leveraging tables, graphs, and figures to present crucial data.

Crafted through a comprehensive approach encompassing surveys, focus groups, interviews, observations, and field trials, this House Dust Mite Allergy market research report is a cornerstone for businesses aiming to shine and succeed. It not only proposes key strategies for new projects within the market but also provides essential data crucial for establishing dominance or making a mark as an emerging player. Serving as a valuable resource, it offers current and forthcoming technical and financial details within the industry.

Understanding consumer trends and supply chain dynamics is pivotal in the House Dust Mite Allergy market. This comprehensive report aids in devising effective strategies for sales, marketing, and promotion amidst a rapidly evolving marketplace. With a dedicated section on the global House Dust Mite Allergy market and its associated companies, including profiles detailing financial outlooks, product portfolios, investment plans, and business strategies, this report offers valuable insights for businesses.

Data Bridge Market Research projects a significant growth rate in the house dust mite allergy market  between 2023 and 2030, expecting a CAGR of approximately 13% during this period. Valued at USD 1.88 billion in 2022, the market is anticipated to reach USD 5 billion by 2030. Alongside market insights like value, growth rates, segments, geographical coverage, and key players, the report includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing insights, and regulatory frameworks, providing a comprehensive understanding of the market landscape.

 

Get a Sample Research Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-house-dust-mite-allergy-treatment-market

As per WHO records of all types of respiratory allergies, around 70% allergic reactions are related with house dust mites. The incidence of allergic rhinitis accounts for approximately 10-25%, globally. Additionally, as per the World Health Organization (WHO), in 2020, it was reported that about 70% of allergic reactions are caused because of house dust mite allergen.

Key Growth Drivers:

Drivers

  • Increasing Drug Approvals

There are different drug approvals by different drug organizations that are helping in boosting the market growth. For instance, in February 2018, Stallergenes Greer and Shionogi & Co., Ltd. received the marketing approval of Actair. It is an allergy immunotherapy drug used to treat house dust mite (HDM) induced allergic rhinitis in Japan. Stallergenes Greer partnered with Shionogi & Co., Ltd. and announced New Drug Application submission for the drug in January 2017. This approval will provide an effective treatment for house dust mite (HDM) induced allergic rhinitis in Japan and will enlarge the business of both the pharmaceutical companies. Furthermore, Merck & Co., Inc. received the U. S. FDA approval in 2017 for Odactra, an anti-allergy drug used to treat house dust mite-induced nasal inflammation in adults. The drug is widely available in oral dosage form and is administered sublingually. This novel drug will deliver a quality treatment to people suffering from house dust mite induced rhinitis and enlarges the business of the company.  

The report outlines the involvement of key players, including:

Shionogi & Co., Ltd (Japan), Stallergenes Greer (Switzerland), Merck & Co., Inc (U.S.), Torii Pharmaceutical Co.,Ltd (Japan), Ergomed plc (U.K.), Allergy Therapeutics (U.K.), DMS Imaging (Belgium), HAL Allergy B.V (Netherlands), Trio Lifescience Private Limited (India), Teva Pharmaceutical Industries Ltd (Israel), ICB PHARMA (Poland), Bayer AG (Germany), Sanofi (France), Catalent, Inc (India), GSK Plc. (U.K.), Merz Pharma (Germany)

Key Market Segmentation

Diagnosis (Skin Prick Test (SPT), Specific IgE Blood Test, Others), Therapy Type (Medication, Immunotherapy, Nasal Irrigation, Others), Route of Administration (Oral, Nasal, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Know More about This Premium Research Report @ https://www.databridgemarketresearch.com/reports/global-house-dust-mite-allergy-treatment-market

Browse More Reports:

 

https://www.databridgemarketresearch.com/reports/global-cyclodextrins-in-pharma-market 
https://www.databridgemarketresearch.com/reports/global-tamiflu-oseltamivir-phosphate-drugs-market 
https://www.databridgemarketresearch.com/reports/global-thrombocytopenia-market 
https://www.databridgemarketresearch.com/reports/global-veterinary-ivf-market 
https://www.databridgemarketresearch.com/reports/global-molecular-modelling-market 
https://www.databridgemarketresearch.com/reports/global-immunodiagnostics-market 
https://www.databridgemarketresearch.com/reports/global-body-composition-analyzers-market 

About Data Bridge Market Research, Private Ltd

Data Bridge Market Research is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe.

Contact Us

US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – corporatesales@databridgemarketresearch.com